Skip to main content
Global Health: Science and Practice logoLink to Global Health: Science and Practice
. 2020 Jun 30;8(2):178–182. doi: 10.9745/GHSP-D-19-00422

Ebola: A Hyperinflated Emergency

Victor K Barbiero a,
PMCID: PMC7326525  PMID: 32430358

As with the Ebola outbreak, global under-5 mortality and morbidity should be considered a public health emergency of international concern.

Key Messages

  • Ebola virus disease outbreaks merit global concern, but worry and response can be hyperinflated.

  • Ebola has killed about 15,266 people globally since 1976. Most recently, 2,267 people have died in the Democratic Republic of the Congo (DRC). However, these numbers pale in comparison to the under-5 deaths globally and in the DRC over the same period.

  • Global child survival should be considered a public health emergency of international concern.

  • Governments, donors, and multilateral organizations should significantly ramp up support for child survival interventions, including sustained system strengthening.


The 2019–2020 Ebola virus disease (EVD) outbreak in the Democratic Republic of the Congo (DRC) was a tragic and significant threat to thousands of people in the DRC and West Africa in general. As of March 25, 2020, an estimated 3,462 people in the DRC have been infected and an estimated 2,267 people have died from this terrible virus. Since EVD was first characterized in 1976, there have been 38 country-specific outbreaks, including the outbreak in the DRC. The total estimated EVD deaths from 1976 to 2020 is 15,266. The median number of deaths for all 38 outbreaks is 29 with a range of 0 to 4,809 (Table 1).1,2

TABLE 1.

Country-Specific Ebola Virus Disease Outbreak Timeline

Year Country Cases, No. Deaths, No. CFR, %
1976 DRC 318 280 88.1
1976 Sudan 284 151 53.2
1977 DRC 1 1 100.0
1979 Sudan 34 22 64.7
1994 Gabon 52 31 59.6
1994 Ivory Coast 1 0 0.0
1995 DRC 315 254 80.6
1996 Gabon 31 21 67.7
1996 Gabon 60 45 75.0
1996 South Africa 1 1 100.0
2000 Uganda 425 224 52.7
2002 Gabon 65 53 81.5
2002 Congo 59 44 74.6
2003 Congo 143 128 89.5
2003 Congo 35 29 82.9
2004 Sudan 17 7 41.2
2005 Congo 12 10 83.3
2007 DRC 264 187 70.8
2007 Uganda 149 37 24.8
2008 DRC 32 14 43.8
2011 Uganda 1 1 100.0
2012 Uganda 24 17 70.8
2012 Uganda 7 4 57.1
2012 DRC 57 29 50.9
2014 Nigeria 20 8 40.0
2014 Mali 8 6 75.0
2014 Senegal 1 0 0.0
2014 USA 4 1 25.0
2014 UK 1 0 0.0
2014 DRC 69 49 71.0
2014 Spain 1 0 0.0
2015 Italy 1 0 0.0
2014–2016 Guinea 3,811 2,543 66.7
2014–2016 Liberia 10,675 4,809 45.0
2014–2016 Sierra Leone 14,124 3,956 28.0
2017 DRC 8 4 50.0
2018 DRC 54 33 61.1
2018–2020a DRC 3,462 2,267 65.5
Total 1976–2020   34,626 15,266 44.1

Abbreviations: CFR, case fatality rate; DRC, the Democratic Republic of the Congo; UK, United Kingdom.

a

Until March 4, 2020.

The EVD case fatality rate (CFR) can be 0 or reach 100%, depending on the scope and location of the outbreak (e.g., 2011 Uganda [1 case 1 death], Senegal 2014 [1 case, 0 deaths]). Although there are 4 different types of Ebola virus,3 generally speaking, the EVD CFR averages about 50%.4 The 2015 outbreak in Guinea, Liberia, and Sierra Leone infected an estimated 28,610 people and killed 11,308 with a CFR of approximately 40%. Without question, EVD is an important and daunting public health issue for Africa and potentially for the world.

However, EVD is an epizootic infection with periodic human exposure and transmission. Since its emergence in 1976; the virus remains an uncomfortable human pathogen. It kills too fast, kills too many, and is not easily transmitted; thus, human outbreaks are limited, and its pandemic potential is moderate to low. It has not yet achieved equilibrium with its human host as it apparently has with its bat host. Furthermore, EVD’s 40%–50% CFR in humans may be considered evolutionarily unsound in many respects for a successful human pathogen.

But, the real issue concerning EVD is disease sensationalism. This can be characterized as an unfounded perception of a global emergency, not necessarily anchored in the epidemiology, pandemic potential, and total mortality of a pathogen. Rather, it appears the classification of a global emergency is based more on the political ramifications, the newsworthiness of the disease de jour, and yes, financial aspects and funding streams of a declared emergency for an emerging and/or reemerging infection. Tragically, more than 11,000 died of EVD in Guinea, Liberia, and Sierra Leone. However, it should be recognized that far more individuals (especially children under 5 years old) died since 1976 in these countries from preventable and treatable but less exotic infections. Should there not be a “moral claim” by the world’s children on emergency resources as well?

In 2014, the Obama administration submitted an emergency funding request, and in 2015, Congress authorized an appropriation of approximately US$5.4 billion in an omnibus emergency bill to combat EVD spread, protect America from an EVD outbreak, and support the development of an EVD vaccine.5 Notably, this appropriation exceeded the total 2015 authorization of US$3.13 billion for all U.S. government assistance for maternal, child, reproductive health, malaria, nutrition, and neglected tropical diseases by US$227 million.6 Did EVD epidemiology and national/global risk justify the emergency bill investment? Perhaps, perhaps not.

Clearly emerging and reemerging infections are important and need to be handled with interventions that mitigate spread and minimize mortality, coupled with adequate and sustained epidemic preparedness. Indeed, there have been concrete benefits for managing future internationally-important outbreaks such as better infection prevention techniques and equipment, improved surveillance methods, better international response, and a better understanding of behavioral determinants and the basic biology of such viruses and techniques for vaccine and therapeutic development. Furthermore, in some countries, lessons learned from the severe acute respiratory syndrome and Middle East respiratory syndrome outbreaks are being applied to the present COVID-19 pandemic.

Hyperinflated, news-based fear; questionable statistical models; and global emergency statements should not justify disproportionate allocations of time and effort on a specific issue of lesser epidemiological impact when millions of people are at risk from diseases that can be prevented, treated, and cured.

It is a sad and tragic fact that from 1976 to present, approximately 34,600 individuals have been infected with EVD and approximately 15,200 have died from EVD (CFR=44.1%) (Table 1). It is noteworthy that the U.S. Centers for Disease Control and Prevention predicted that the 2014–2016 West African EVD outbreak could have infected more than 1.4 million people in Liberia and Sierra Leone alone7:

Extrapolating trends to January 20, 2015, without additional interventions or changes in community behavior (e.g., notable reductions in unsafe burial practices), the model also estimates that Liberia and Sierra Leone will have approximately 550,000 Ebola cases (1.4 million when corrected for underreporting).

Over the period from 1976 to 2017, in the DRC alone approximately 12.43 million children under 5 years old have died, mostly from preventable and curable childhood diseases (Table 2)8 (Figure).2 This number dwarfs the 15,266 people who have died from EVD globally over the same period. Furthermore, at the global level, annually, an estimated 5.3 million children under 5 years old die from preventable and curable causes worldwide.9 Which qualifies as a more urgent and important global health emergency: global EVD or global under-5 mortality?

TABLE 2.

Under-5 Deaths in the Democratic Republic of the Congo from 1976–20178a

Year
Estimated Level 1976 1977 1978 1979 1980 1981 1982 1983 1984 1985 1986 Total Deaths
Low 196,957 200,518 204,337 208,117 211,628 215,118 219,168 222,591 226,628 231,114 235,707 2,371,883
Medium 233,087 235,767 238,287 241,006 243,644 246,468 249,515 252,490 255,711 259,276 263,126 2,718,377
High 275,619 276,160 277,290 278,019 279,506 280,937 282,416 284,257 286,999 289,612 292,898 3,103,713
                       
1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 Total Deaths
Low 240,269 245,357 250,850 256,597 262,380 268,588 275,015 281,307 287,517 292,755 296,860 2,957,495
Medium 267,689 272,359 277,624 283,090 289,076 295,539 302,429 309,281 315,772 321,800 326,733 3,261,392
High 296,555 301,225 306,764 312,320 318,881 326,150 333,311 341,237 348,421 355,187 360,844 3,600,895
                         
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 Total Deaths
Low 299,906 301,930 302,590 302,362 301,596 300,522 298,587 295,532 291,987 287,351 281,512 3,263,875
Medium 330,528 332,688 333,792 333,850 333,311 332,597 331,277 329,811 328,038 326,465 324,650 3,637,007
High 365,124 368,169 369,844 370,391 370,239 369,727 368,988 368,562 369,274 371,071 373,064 4,064,453
                         
2009 2010 2011 2012 2013 2014 2015 2016 2017 Total Deaths
Low 274,783 267,800 259,746 251,199 243,411 234,782 225,454 216,143 206,535     2,179,853
Medium 322,801 320,391 318,265 315,758 313,762 310,711 307,687 303,618 300,265     2,813,258
High 375,987 380,011 383,529 387,635 393,306 399,404 405,716 415,115 422,796     3,563,499
                         
Totals 1976–2017 Total Deaths
    Low                       10,773,106
    Medium                       12,430,034
    High                       14,332,560
a

As of December 19, 2019.

FIGURE.

FIGURE.

Estimated Cumulative Under-5 Mortality in the Democratic Republic of the Congo Versus Global Ebola Virus Disease Mortality, 1976–2017a,2,8

aNote: Ebola virus disease mortality not to scale.

The term public health emergency of international concern (PHEIC) is defined in the International Health Regulations (2005) as:

An extraordinary event, which is determined, as provided in these Regulations: to constitute a public health risk to other States through the international spread of disease; and to potentially require a coordinated international response. This definition implies a situation that: is serious, unusual or unexpected; carries implications for public health beyond the affected State’s national border; and may require immediate international action.10

The PHEIC definition accurately describes an epidemiological emergency. However, it falls short on quantifying the impact of the emergency on existing and/or potential morbidity and mortality on a national, regional, or global scale. As noted, the burden of disease for children under 5 years old dramatically exceeds the cumulative global morbidity and mortality from EVD. Considering measles alone, from January 2019 through November 2019, the United Nations Children’s Fund reported 5,000 measles deaths (90% in children under 5 years old) in the DRC, with over 200,000 measles cases.11,12 Globally, measles surged in 2019 and killed about 140,000 worldwide,13 which is about 9.2 times the total number of deaths caused by EVD in its 43-year history as a human pathogen.

Clearly, great success has been achieved over the last 25 years in reducing deaths in children under 5 years old. However, in my view, the “unfinished agenda for child survival,”14 also qualifies as a public health emergency that should be of international concern. It deserves heightened attention by the governments, multilateral and bilateral donors alike, and should not be marginalized. Every day, approximately 14,500 children under 5 years old die, the equivalent of 35 Boeing 747 plane crashes.15 Clearly, global child mortality fits the World Health Organization’s definition of a “Grade 3” emergency and should be categorized as such.16 We need increased and continuous global investment in child survival and sustainable health system development.17 The moral claim of the world’s children should no longer be ignored.

The “unfinished agenda for child survival,” also qualifies as a public health emergency that should be of international concern.

First published online: May 19, 2020

Cite this article as: Barbiero VK. Ebola: a hyperinflated emergency. Glob Health Sci Pract. 2020;8(2):178-182. https://doi.org/10.9745/GHSP-D-19-00422

REFERENCES


Articles from Global Health: Science and Practice are provided here courtesy of The Johns Hopkins Bloomberg School of Public Health Center for Communication Programs

RESOURCES